NEW YORK (GenomeWeb News) – Transgenomic yesterday reported a 21.2 percent increase in first-quarter revenues and a profit versus a loss a year earlier.
 
The Omaha, Neb.-based cancer genetic test provider said that it brought in revenues of $6.3 million for the three-month period ended March 31, compared to revenues of $5.2 million for the first quarter of 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.